CHS INC - CHSINC 8 PERP (CHSCP) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:CHSCP • US12542R2094

28.44 USD
+0.02 (+0.07%)
Last: Feb 11, 2026, 08:12 PM
Fundamental Rating

3

Overall CHSCP gets a fundamental rating of 3 out of 10. We evaluated CHSCP against 88 industry peers in the Food Products industry. Both the profitability and financial health of CHSCP have multiple concerns. CHSCP is valued expensive and it does not seem to be growing. Finally CHSCP also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year CHSCP had a positive cash flow from operations.
  • In the past 5 years CHSCP has always been profitable.
  • In the past 5 years CHSCP always reported a positive cash flow from operatings.
CHSCP Yearly Net Income VS EBIT VS OCF VS FCFCHSCP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

1.2 Ratios

  • The Return On Assets of CHSCP (3.17%) is comparable to the rest of the industry.
  • The Return On Equity of CHSCP (5.40%) is comparable to the rest of the industry.
  • CHSCP's Return On Invested Capital of 0.49% is on the low side compared to the rest of the industry. CHSCP is outperformed by 62.50% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CHSCP is significantly below the industry average of 27.73%.
Industry RankSector Rank
ROA 3.17%
ROE 5.4%
ROIC 0.49%
ROA(3y)6.36%
ROA(5y)6.23%
ROE(3y)11.28%
ROE(5y)11.55%
ROIC(3y)3.89%
ROIC(5y)4.02%
CHSCP Yearly ROA, ROE, ROICCHSCP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • CHSCP has a Profit Margin of 1.69%. This is comparable to the rest of the industry: CHSCP outperforms 50.00% of its industry peers.
  • CHSCP's Profit Margin has improved in the last couple of years.
  • The Operating Margin of CHSCP (0.26%) is worse than 63.64% of its industry peers.
  • In the last couple of years the Operating Margin of CHSCP has declined.
  • With a Gross Margin value of 3.21%, CHSCP is not doing good in the industry: 86.36% of the companies in the same industry are doing better.
  • CHSCP's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 0.26%
PM (TTM) 1.69%
GM 3.21%
OM growth 3Y-52.33%
OM growth 5Y-23.53%
PM growth 3Y-21.71%
PM growth 5Y2.56%
GM growth 3Y-10.36%
GM growth 5Y-1.5%
CHSCP Yearly Profit, Operating, Gross MarginsCHSCP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4 5

3

2. Health

2.1 Basic Checks

  • CHSCP has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, CHSCP has a worse debt to assets ratio.
CHSCP Yearly Shares OutstandingCHSCP Yearly Shares OutstandingYearly Shares Outstanding 2018 2M 4M 6M 8M 10M
CHSCP Yearly Total Debt VS Total AssetsCHSCP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • CHSCP has an Altman-Z score of 2.32. This is not the best score and indicates that CHSCP is in the grey zone with still only limited risk for bankruptcy at the moment.
  • With a Altman-Z score value of 2.32, CHSCP perfoms like the industry average, outperforming 57.95% of the companies in the same industry.
  • A Debt/Equity ratio of 0.26 indicates that CHSCP is not too dependend on debt financing.
  • CHSCP's Debt to Equity ratio of 0.26 is fine compared to the rest of the industry. CHSCP outperforms 62.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z 2.32
ROIC/WACC0.09
WACC5.58%
CHSCP Yearly LT Debt VS Equity VS FCFCHSCP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B 10B

2.3 Liquidity

  • CHSCP has a Current Ratio of 1.53. This is a normal value and indicates that CHSCP is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.53, CHSCP perfoms like the industry average, outperforming 45.45% of the companies in the same industry.
  • A Quick Ratio of 0.91 indicates that CHSCP may have some problems paying its short term obligations.
  • CHSCP has a Quick ratio of 0.91. This is comparable to the rest of the industry: CHSCP outperforms 48.86% of its industry peers.
Industry RankSector Rank
Current Ratio 1.53
Quick Ratio 0.91
CHSCP Yearly Current Assets VS Current LiabilitesCHSCP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

1

3. Growth

3.1 Past

  • The Revenue has decreased by -9.68% in the past year.
  • The Revenue has been growing slightly by 4.54% on average over the past years.
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-9.68%
Revenue growth 3Y-9.47%
Revenue growth 5Y4.54%
Sales Q2Q%-6.19%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHSCP Yearly Revenue VS EstimatesCHSCP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

1

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
CHSCP Price Earnings VS Forward Price EarningsCHSCP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CHSCP indicates a rather cheap valuation: CHSCP is cheaper than 92.05% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.5
CHSCP Per share dataCHSCP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 500 1K 1.5K 2K 2.5K

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

8

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 7.30%, CHSCP is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 2.23, CHSCP pays a better dividend. On top of this CHSCP pays more dividend than 95.45% of the companies listed in the same industry.
  • CHSCP's Dividend Yield is rather good when compared to the S&P500 average which is at 1.80.
Industry RankSector Rank
Dividend Yield 7.3%

5.2 History

  • CHSCP has paid a dividend for at least 10 years, which is a reliable track record.
  • CHSCP has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years21
CHSCP Yearly Dividends per shareCHSCP Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • 28.20% of the earnings are spent on dividend by CHSCP. This is a low number and sustainable payout ratio.
DP28.2%
EPS Next 2YN/A
EPS Next 3YN/A
CHSCP Yearly Income VS Free CF VS DividendCHSCP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B 2.5B
CHSCP Dividend Payout.CHSCP Dividend Payout, showing the Payout Ratio.CHSCP Dividend Payout.PayoutRetained Earnings

CHS INC - CHSINC 8 PERP

NASDAQ:CHSCP (2/11/2026, 8:12:36 PM)

28.44

+0.02 (+0.07%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)01-06
Earnings (Next)03-31
Inst Owners11.23%
Inst Owner Change0%
Ins Owners0.04%
Ins Owner Change0%
Market Cap348.96M
Revenue(TTM)35.46B
Net Income(TTM)598.13M
Analysts0
Price TargetN/A
Short Float %0.07%
Short Ratio0.56
Dividend
Industry RankSector Rank
Dividend Yield 7.3%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP28.2%
Div Incr Years0
Div Non Decr Years21
Ex-Date03-17
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF 0.55
P/B 0.03
P/tB 0.03
EV/EBITDA 2.5
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-7.56
FCFYN/A
OCF(TTM)51.82
OCFY182.2%
SpS2890.18
BVpS902.75
TBVpS902.75
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 3.17%
ROE 5.4%
ROCE 0.67%
ROIC 0.49%
ROICexc 0.5%
ROICexgc 0.5%
OM 0.26%
PM (TTM) 1.69%
GM 3.21%
FCFM N/A
ROA(3y)6.36%
ROA(5y)6.23%
ROE(3y)11.28%
ROE(5y)11.55%
ROIC(3y)3.89%
ROIC(5y)4.02%
ROICexc(3y)4.33%
ROICexc(5y)4.38%
ROICexgc(3y)4.41%
ROICexgc(5y)4.46%
ROCE(3y)5.12%
ROCE(5y)5.34%
ROICexgc growth 3Y-59.71%
ROICexgc growth 5Y-22%
ROICexc growth 3Y-59.75%
ROICexc growth 5Y-22.29%
OM growth 3Y-52.33%
OM growth 5Y-23.53%
PM growth 3Y-21.71%
PM growth 5Y2.56%
GM growth 3Y-10.36%
GM growth 5Y-1.5%
F-Score5
Asset Turnover1.88
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Debt/EBITDA 3.9
Cap/Depr 111.84%
Cap/Sales 2.05%
Interest Coverage 0.62
Cash Conversion 85.64%
Profit Quality N/A
Current Ratio 1.53
Quick Ratio 0.91
Altman-Z 2.32
F-Score5
WACC5.58%
ROIC/WACC0.09
Cap/Depr(3y)119.46%
Cap/Depr(5y)96.76%
Cap/Sales(3y)1.78%
Cap/Sales(5y)1.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.68%
Revenue growth 3Y-9.47%
Revenue growth 5Y4.54%
Sales Q2Q%-6.19%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-84.43%
EBIT growth 3Y-56.84%
EBIT growth 5Y-20.06%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-119.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-50.05%
OCF growth 3Y-31.13%
OCF growth 5Y-10.17%

CHS INC - CHSINC 8 PERP / CHSCP FAQ

What is the fundamental rating for CHSCP stock?

ChartMill assigns a fundamental rating of 3 / 10 to CHSCP.


Can you provide the valuation status for CHS INC - CHSINC 8 PERP?

ChartMill assigns a valuation rating of 1 / 10 to CHS INC - CHSINC 8 PERP (CHSCP). This can be considered as Overvalued.


Can you provide the profitability details for CHS INC - CHSINC 8 PERP?

CHS INC - CHSINC 8 PERP (CHSCP) has a profitability rating of 3 / 10.


How sustainable is the dividend of CHS INC - CHSINC 8 PERP (CHSCP) stock?

The dividend rating of CHS INC - CHSINC 8 PERP (CHSCP) is 8 / 10 and the dividend payout ratio is 28.2%.